The Federal Trade Commission has been most vigilant in assuming a prominent role in promoting the health of our citizenry by taking the needed steps to ensure PSAPs are used as intended, as so described by the U.S. Food and Drug Administration. The FDA states that hearing aids and PSAPs differ “in that only hearing aids are intended to make up for impaired hearing…”. Choosing a PSAP as a substitute for a hearing aid can lead to more damage to your hearing.” To this end, in recent litigation, the FTC settled a suit against a party who overstated the merits of a sound amplifier and stated that it was suspending a judgment of $47 million given the defendants agreement to “an order that will require them to have human clinical testing to support future representations.”
